DYNDyne Therapeutics, Inc.
$16.65+27% 1Y
$16.65
$12.3752 weeks$26.80
The financials
Dyne Therapeutics, Inc. by the numbers
The next results filing is expected around Nov 4, 2026, the same week as a year ago.
| Income statement | Q2 2026 | Q2 2025 | Change |
|---|---|---|---|
| Operating income | −$182M | −$116M | n/a |
| Net income | −$179M | −$111M | n/a |
| Diluted EPS | −$1.08 | −$0.97 | n/a |
On our screens:Most shorted stocks